Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

PepGen Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK--(BUSINESS WIRE)---- $PEPG #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST PEPGEN INC. (PEPGEN OR THE COMPANY) (NASDAQ: PEPG) AND REMINDS INVESTORS OF THE AUGUST 11, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. FARUQI & FARUQI IS A LEADING NATIONAL SECURITIES LAW FIRM WITH OFFICES IN NEW YORK, PENNSYLVANIA, CALIFORNIA AND GEORGIA. THE FIRM HAS REC.

FINAL DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PEPGEN

BRAGAR EAGEL & SQUIRE, P.C. LITIGATION ATTORNEYS ENCOURAGE INVESTORS WHO SUFFERED LOSSES IN PEPGEN (PEPG) TO CONTACT THEM DIRECTLY TO DISCUSS THEIR OPTIONS

PEPGEN (PEPG) FINAL DEADLINE ALERT: BRAGAR EAGEL & SQUIRE, P.C. REMINDS PEPGEN INVESTORS OF THE AUGUST 8TH DEADLINE AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

INVESTORS CAN CONTACT THE LAW FIRM AT NO COST TO LEARN MORE ABOUT RECOVERING THEIR LOSSES

PEPGEN INC. INVESTORS: PLEASE CONTACT THE PORTNOY LAW FIRM TO RECOVER YOUR LOSSES. AUGUST 8, 2025 DEADLINE TO FILE LEAD PLAINTIFF MOTION.

PEPGEN (PEPG) URGENT DEADLINE ALERT: BRAGAR EAGEL & SQUIRE, P.C. REMINDS PEPGEN INVESTORS OF THE AUGUST 8TH DEADLINE AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

PEPGEN INC. INVESTORS: PLEASE CONTACT THE PORTNOY LAW FIRM TO RECOVER YOUR LOSSES; AUGUST 8, 2025 DEADLINE TO FILE LEAD PLAINTIFF MOTION

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $50,000 IN PEPGEN TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS

DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PEPGEN

NEW YORK , AUG. 5, 2025 /PRNEWSWIRE/ --LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN PEPGEN INC. ("PEPGEN INC." OR THE "COMPANY") (NASDAQ: PEPG) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF PEPGEN INC. INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD BETWEEN MARCH 7, 2024 AND MARCH 3, 2025.

PEPGEN INC. SUED FOR SECURITIES LAW VIOLATIONS - CONTACT LEVI & KORSINSKY BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS - PEPG

NEW YORK, AUG. 04, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

PEPGEN INC. SUED FOR SECURITIES LAW VIOLATIONS - CONTACT THE GROSS LAW FIRM BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS  PEPG

NEW YORK , AUG. 1, 2025 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN PEPGEN INC. ("PEPGEN INC." OR THE "COMPANY") (NASDAQ: PEPG) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF PEPGEN INC. INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD BETWEEN MARCH 7, 2024 AND MARCH 3, 2025.

PEPGEN INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT LEVI & KORSINSKY BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS - PEPG

SHAREHOLDER NOTICE: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PEPGEN

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $50,000 IN PEPGEN TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU SUFFERED LOSSES EXCEEDING $50,000 IN PEPGEN BETWEEN MARCH 7, 2024 AND MARCH 3, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK , JULY 29, 2025 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST PEPGEN INC. ("PEPGEN" OR THE "COMPANY") (NASDAQ: PEPG) AND REMINDS INVESTORS OF THE AUGUST 11, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

INVESTOR DEADLINE APPROACHING: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PEPGEN

NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS INVESTORS THAT A SHAREHOLDER FILED A CLASS ACTION LAWSUIT ON BEHALF OF PURCHASERS OF SECURITIES OF PEPGEN INC. (NASDAQ: PEPG) SECURITIES BETWEEN MARCH 7, 2024 AND MARCH 3, 2025. PEPGEN IS A CLINICAL-STAGE BIOTECHNOLOGY COMPANY. FOR MORE INFORMATION, SUBMIT A FORM, EMAIL ATTORNEY PHILLIP KIM, OR GIVE US A CALL AT 866-767-3653. THE ALLEGATIONS: ROSEN LAW FIRM IS INVESTIGATING THE ALLEGATIONS THAT PEPGEN INC. (NA.

PEPG DEADLINE: ROSEN LAW FIRM URGES PEPGEN INC. (NASDAQ: PEPG) STOCKHOLDERS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM FOR INFORMATION ABOUT THEIR RIGHTS

NEW YORK, JULY 24, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

SHAREHOLDERS OF PEPGEN INC. SHOULD CONTACT THE GROSS LAW FIRM BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS  PEPG

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $50,000 IN PEPGEN TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU SUFFERED LOSSES EXCEEDING $50,000 IN PEPGEN BETWEEN MARCH 7, 2024 AND MARCH 3, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK , JULY 23, 2025 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST PEPGEN INC. ("PEPGEN" OR THE "COMPANY") (NASDAQ: PEPG) AND REMINDS INVESTORS OF THE AUGUST 11, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

SHAREHOLDER REMINDER: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PEPGEN

NEW YORK, JULY 17, 2025 (GLOBE NEWSWIRE) -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN PEPGEN INC. ("PEPGEN INC." OR THE "COMPANY") (NASDAQ: PEPG) OF A CLASS ACTION SECURITIES LAWSUIT.

SHAREHOLDERS OF PEPGEN INC. SHOULD CONTACT LEVI & KORSINSKY BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS  PEPG

NEW YORK, JULY 16, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN PEPGEN TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS

NEW YORK, JULY 10, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

NEW YORK , JULY 10, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG). SHAREHOLDERS WHO PURCHASED SHARES OF PEPG DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.

PEPGEN INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT THE GROSS LAW FIRM BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS - PEPG

NEW YORK , JULY 7, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG). SHAREHOLDERS WHO PURCHASED SHARES OF PEPG DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.

PEPGEN INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT THE GROSS LAW FIRM FOR MORE INFORMATION - PEPG

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN PEPGEN TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN PEPGEN BETWEEN MARCH 7, 2024 AND MARCH 3, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK , JULY 3, 2025 /PRNEWSWIRE/ --FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST PEPGEN INC. ("PEPGEN" OR THE "COMPANY") (NASDAQ: PEPG) AND REMINDS INVESTORS OF THE AUGUST 11, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

NEW YORK, JULY 02, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

NEW YORK, JUNE 23, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

INVESTORS IN PEPGEN INC. SHOULD CONTACT THE GROSS LAW FIRM BEFORE AUGUST 8, 2025 TO DISCUSS YOUR RIGHTS  PEPG

NEW YORK, JUNE 18, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF PEPGEN INC. (NASDAQ: PEPG).

PepGen Inc.

PEPG

Price

Financials Overview

Financial Reports

No items found.

Press Releases

PepGen Inc.

PEPG.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

PEPG